COVID-19 Raises Heart Attack, Stroke Risk for Up to Three Years
Individuals infected with COVID-19 early in the pandemic faced an increased risk of heart attack, stroke, and death for up to three years following initial infection.
Individuals infected with COVID-19 early in the pandemic faced an increased risk of heart attack, stroke, and death for up to three years following initial infection.
NIH-backed research reveals diabetics taking metformin have a lower risk of developing long COVID or dying after infection compared to those on other diabetes medications.
Adolescents were most likely to experience low energy/tiredness, while children were most likely to report headache.
Backed by a $3.8 million NIH grant, researchers are investigating how hormones impact influenza in men and women.
Pfizer's Abrysvo demonstrated a strong immune response and favorable safety profile in immunocompromised adults at high risk of severe RSV.
The CDC has issued a health advisory in response to an increase in parvovirus B19 activity across the United States.Â